Retrospective analysis of cerebral neurological complications against background of seasonal respiratory viral infections and new coronavirus infection Covid‑19
https://doi.org/10.33667/2078-5631-2021-36-47-51
Abstract
Based on the example of seasonal epidemics of respiratory viral infections, it is partially possible to model the outcomes of neurological complications from Covid‑19, taking into account the pathogenetic features of the virus effect on the vascular wall and nerve cells. The accumulated experience of doctors of various specialties makes it possible to prevent such life-threatening complications as ACVA, PATE, intoxication, and sepsis. From the first days of the disease, it is necessary to conduct dynamic monitoring of blood rheology, the level of systemic oxygenation, use anticoagulants in preventive doses in patients at the early stages of the disease, conduct therapy aimed at reducing the risk of cytokine storm development.
About the Authors
M. A. PrivalovaRussian Federation
Privalova Maria A., PhD Med, head of Neurological Dept for Patients with Stroke
Saint Petersburg
M. G. Sokolova
Russian Federation
Sokolova Maria G., DM Sci (habil.), associate professor at Dept of Neurology n. a. acad. S. N. Davidenkov
Saint Petersburg
M. Yu. Kabanov
Russian Federation
Kabanov Maxim Yu., DM Sci (habil.), professor, head of the Hospital
Saint Petersburg
O. N. Zueva
Russian Federation
Zueva Olga N., PhD Med, deputy head of the Hospital for Neurology
Saint Petersburg
I. A. Bоzhkov
Russian Federation
Bozhkov Igor A., DM Sci (habil.), professor at Dept of Public Health, Economics and
Healthcare Management
Saint Petersburg
E. V. Lopatina
Russian Federation
Lopatina Ekaterina V., Doctor Bio Sci, leading researcher at Laboratories of Physiology of Cardiovascular System and Lymphalogy
Saint Petersburg
Yu. I. Polyakov
Russian Federation
Polyakov Yury I., DM Sci (habil.), professor at Dept of Psychiatry
Saint Petersburg
References
1. Barinov A. N., Moshkhoeva L. S., Parkhomenko E. V., Emikh E. V., Yastrebtseva I. P. Clinical features, pathogenesis and treatment of long-haul COVID-19 impact on nervous system. Medical Alphabet. 2021; (3): 14–22. (In Russ.) https://doi.org/10.33667/2078–5631–2021–3–14–22
2. Voznyuk I. A., Ilina O. M., Kolomentsev S. V. Ischemic stroke as a clinical form and pathogenetic model in the structure of central nervous system damage in COVID-19. Bulletin of Restorative Medicine. 2020. No. 4 (98). pp. 90–98.
3. Golovacheva V. A., Tabeeva G. R., Kuznetsov I. V. Cognitive disorders in COVID-19: interrelation, pathogenesis and questions of therapy. Neurology, Neuropsychiatry, Psychosomatics. 2021. Vol. 13. No. 2. pp. 123–129.
4. Gusev E. I., Martynov M. Yu., Boyko A. N., Voznyuk I. A., Lash N. Yu., Sivertseva S. A., Spirin N. N., Shamalov N. A. New coronavirus infection (COVID‑19) and damage to the nervous system: mechanisms of neurological disorders, clinical manifestations, organization of neurological care. S. S. Korsakov. 2020. Vol. 120. No. 6. pp. 7–16.
5. Demyanovskaya E. G., Kryzhanovsky S. M., Vasiliev A. S., Shmyrev V. I. Neurological aspects of COVID-19. Tactics of patient management by a neurologist taking into account the epidemiological situation. The Attending Physician. 2021. No. 2. pp. 54–60.
6. Ivanova A. A., Shamsheva O. V., Shchederkina I. O. Studying the role of an infectious factor in the development of stroke in children. Results of a 5-year retrospective analysis. Children's Infections. 2021. Vol. 20. No. 2. pp. 10–15.
7. The Scientific Heritage. 2021. № 63–2. С. 15–18. Kovalenko T., Sirotnikov D., Shtanyuk E. Central nervous system damage as a complication of COVID-19. Actual problems and general concepts of symptoms of CNS and PNS lesions in patients with COVID-19. The Scientific Heritage. 2021. No. 63–2. pp. 15–18.
8. Kovner A. V., Kurskaya O. G., Shestopalov A. M. Pathogenesis of damage to the frontal cortex of the brain in mice against the background of infection with seasonal influenza virus A/H1N 1. Siberian Scientific Medical Journal. 2019. Vol. 39. No. 2. pp. 5–10.
9. Kozhasheva A. E., Belesbek S. O., Abdimitova DZh., Saken B. M., Borikhodzhayeva A. P., Baymukhambetova Z. B. COVID‑19 and stroke: possible causes and pathogenesis of development (literary review). Bulletin of the Kazakh National Medical University. 2021. No. 1. pp. 103–110.
10. Novikova L. B., Akopyan A. P., Sharapova K. M., Latypova R. F. Neurological and mental disorders associated with COVID-19. Arterial Hypertension. 2020. Vol. 26. No. 3. pp. 317–326.
11. Ostroumova T. M., Ostroumova O. D., Arablinsky N. A., Golovina O. V. Stroke and COVID-19. Medical alphabet. 2021. No. 1. pp. 26–30.
12. Roganova I. V. Predicting the state of venous blood flow through the vessels of the brain region in patients with influenza. Bulletin of the medical Institute «Reaviz»: rehabilitation, doctor and health. 2019. No. 1 (37). pp. 115–120.
13. Rodionova O. V., Sorokoumov V. A. Neurological diseases in the conditions of the CAVID-19 pandemic (literature review). Scientific notes of the Pavlov St. Petersburg State Medical University. 2020. Vol. 27. No. 2. pp. 18–24.
14. Tanashyan M. M., Kuznetsova P. I., Raskurazhev A. A. Neurological aspects of COVID-19. Annals of Clinical and Experimental Neurology. 2020. Vol. 14. No. 2. pp. 62–69.
15. Tsygan N. V., Ryabtsev A. V., Yakovleva V. A., Odinak M. M., Litvinenko I. V. Epidemiology, pattern and pathogenesis of neurological disorders in a new coronavirus infection. Bulletin of the Russian Military Medical Academy. 2020. No. S 3. pp. 102–104.
16. Respiratory infections as a trigger of acute myocardial infarction and stroke. Practical Pulmonology. 2018. No. 1. pp. 107–108.
17. Ahmad I., Rathore F. A. Neurological manifestations and complications of COVID-19: a literature review. Journal of Clinical Neuroscience. 2020. Vol. 77. P. 8–12.
18. Banerjee D., Viswanath B Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: insights from other coronaviruses. Asian Journal of Psychiatry. 2020. Vol. 54. P. 102–350.
19. Beghi E. COVID-19 infection and neurological complications: present findings and future predictions. Neuroepidemiology. 2020. Vol. 54. No. 4. P. 1–6.
20. Cantan B., Luyt CE, Martin-Loeches I. Martin-Loeches I. Influenza infections and emergent viral infections in intensive care unit. Seminars in respiratory and critical care medicine. 2019. Vol. 40. No. 04. P. 488–497.
21. Desforges M., Le Coupanec A., Dubeau Ph., Bourgouin A., Lajoie L., Dubé M., Talbot P. J. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2020. Vol. 12. No. 1. P. 14.
22. Ladecola C., Anrather J., Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020. Vol. 183. No. 1. P. 16–27.
23. Paksu M. S., Aslan K., Kendirli T., Akyildiz B. N., Yener N., Yildizdas R. D., Davutoglu M., Yaman A., Isikay S., Sensoy G., Tasdemir H. A. Neuroinfluenza: evaluation of seasonal influenza associated severe neurological complications in children (a multicenter study). Child's Nervous System. 2018. Vol. 34. No. 2. P. 335–347.
24. Radzišauskienė D., Vitkauskaitė M., Žvinytė K., Mameniškienė R. Neurological complications of pandemic A (H1N 1) 2009pdm, postpandemic A (H1N 1) v, and seasonal influenza A. Brain and behavior. 2021. Vol. 11. No. 1.
25. Robinson C. P., Busl K. M. Neurologic manifestations of severe respiratory viral contagions. Critical care explorations. 2020. Vol. 2. No. 4.
Review
For citations:
Privalova M.A., Sokolova M.G., Kabanov M.Yu., Zueva O.N., Bоzhkov I.A., Lopatina E.V., Polyakov Yu.I. Retrospective analysis of cerebral neurological complications against background of seasonal respiratory viral infections and new coronavirus infection Covid‑19. Medical alphabet. 2021;(36):47-51. (In Russ.) https://doi.org/10.33667/2078-5631-2021-36-47-51